Name: LBRX Balance Sheet - Lb Pharmaceuticals Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

LBRX - Lb Pharmaceuticals Inc.

USD | NASDAQ | Healthcare

LBRX Balance Sheet - Lb Pharmaceuticals Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023
Cash And Short Term Investments
Cash And Equivalents	250.2	23.0	-
Restricted Cash	-	-	-
Short Term Investments	45.0	5.0	-
Cash And Short Term Investments	295.2	28.0	-
Receivables
Accounts Receivable	-	-	-
Current Assets
Inventory	-	-	-
Prepaid Expenses	13.2	0.9	-
Other Current Assets	-	-	-
Assets Held For Sale	-
Non-Current Assets
Property, Plant & Equipment Gross	2.0	2.0	-
Accumulated Depreciation	0.4	0.1	-
Property,Plant & Equipment Net	1.6	1.9	-
Long Term Investments
Current Liabilities
Accounts Payable	2.1	2.3	-
Short Term Debt	-	-	-
Deferred Revenue Current	-	-	-
Operating Lease Liabilities Current
Non-Current Liabilities
Long Term Debt	-	-	-
Operating Lease Liabilities Non-Current	2.8	3.2	-
Deferred Revenue Non-Current	-	-	-
Deferred Tax Liabilities
Common Equity
Common Stock	0.0	0.0	-
Additional Paid In Capital	-	-	-
Retained Earnings	(129.5)	(104.3)	-
Accumulated Other Comprehensive Income
Supplementary Data
Total Debt	-	-	-
Net debt	-	-	-
Working Capital	301.0	20.8	-
Book Value	301.3

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23
Cash And Short Term Investments
Cash And Equivalents	320.7	250.2	-	-	23.0	-	-	-	-
Restricted Cash	-	-	-	-	-	-	-	-	-
Short Term Investments	45.0	45.0	-	-	5.0	-	-	-	-
Cash And Short Term Investments	365.6	295.2	-	-	28.0	-	-	-	-
Receivables
Accounts Receivable	-	-	-	-	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-	-	-	-
Prepaid Expenses	23.4	13.2	-	-	0.9
Non-Current Assets
Property, Plant & Equipment Gross	2.0	2.0	-	-	2.0	-	-	-	-
Accumulated Depreciation	0.5	0.4	-	-
Current Liabilities
Accounts Payable	7.1	2.1	-	-	2.3	-	-	-	-
Short Term Debt	-	-	-	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	2.7	2.8	-	-
Common Equity
Common Stock	0.0	0.0	-	-	0.0	-	-	-	-
Additional Paid In Capital	-	-	-	-	-
Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-
Net debt	-	-	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)